Performance analysis of AIM ImmunoTech (AIM)
Annual Return
Over the past 3 years, AIM has had an average annual return of -95.59%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, AIM has had an average annual return of -95.59%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, AIM has had an average annual return of -95.59%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Dec 28, 2006, AIM has had an average annual return of -15.20%, underperforming the benchmark SPY, which returned +10.82% annual.
| 2026 | 2025 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -77.16% | -85.42% | +108.88% | +15.95% | -7.25% | -21.58% | +528.51% | -85.42% | -28.36% | +3.08% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.90% | -18.63% | -35.53% | -11.41% | -21.39% | -30.29% | -11.97% | -77.16% | |||||
| 2025 | +11.62% | -66.25% | -16.10% | +11.83% | -23.35% | -27.64% | -25.66% | -85.42% |
Drawdown analysis of AIM ImmunoTech (AIM)
The maximum drawdown for the AIM was -97.64%, occurring on May 26, 2026. This drawdown has not yet recovered.
The current AIM drawdown is -97.46%.
Since Dec 28, 2006 AIM has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.64% | Jun 17, 2025 | 235 | May 26, 2026 | Ongoing | Ongoing | Ongoing |
| -95.15% | Jan 8, 2007 | 495 | Dec 23, 2008 | 1121 | Jun 17, 2025 | 1616 |